<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34867943</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.</ArticleTitle><Pagination><StartPage>710217</StartPage><MedlinePgn>710217</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">710217</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.710217</ELocationID><Abstract><AbstractText>Severe SARS-CoV-2 infection can trigger uncontrolled innate and adaptive immune responses, which are commonly associated with lymphopenia and increased neutrophil counts. However, whether the immune abnormalities observed in mild to severely infected patients persist into convalescence remains unclear. Herein, comparisons were drawn between the immune responses of COVID-19 infected and convalescent adults. Strikingly, survivors of severe COVID-19 had decreased proportions of NKT and V&#x3b4;2 T cells, and increased proportions of low-density neutrophils, IgA+/CD86+/CD123+ non-classical monocytes and hyperactivated HLADR+CD38+ CD8+ T cells, and elevated levels of pro-inflammatory cytokines such as hepatocyte growth factor and vascular endothelial growth factor A, long after virus clearance. Our study suggests potential immune correlates of "long COVID-19", and defines key cells and cytokines that delineate true and quasi-convalescent states.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Lim, Puan, Wang, Teng, Loh, Tan, Carissimo, Chan, Poh, Lee, Fong, Yeo, Chee, Amrun, Chang, Tay, Torres-Ruesta, Leo Fernandez, How, Andiappan, Lee, Duan, Tan, Yan, Kalimuddin, Lye, Leo, Ong, Young, Renia, Ng, Lee and R&#xf6;tzschke.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jackwee</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puan</LastName><ForeName>Kia Joo</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liang Wei</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teng</LastName><ForeName>Karen Wei Weng</ForeName><Initials>KWW</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loh</LastName><ForeName>Chiew Yee</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kim Peng</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carissimo</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yi-Hao</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poh</LastName><ForeName>Chek Meng</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Cheryl Yi-Pin</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Siew-Wai</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Nicholas Kim-Wah</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chee</LastName><ForeName>Rhonda Sin-Ling</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amrun</LastName><ForeName>Siti Naqiah</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Zi Wei</ForeName><Initials>ZW</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tay</LastName><ForeName>Matthew Zirui</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Ruesta</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leo Fernandez</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>How</LastName><ForeName>Wilson</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andiappan</LastName><ForeName>Anand Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Kaibo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Seow-Yen</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Changi General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, National University Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalimuddin</LastName><ForeName>Shirin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lye</LastName><ForeName>David Chien</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>National Centre for Infectious Diseases, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leo</LastName><ForeName>Yee-Sin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>National Centre for Infectious Diseases, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Sean W X</ForeName><Initials>SWX</Initials><AffiliationInfo><Affiliation>National Centre for Infectious Diseases, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Barnaby E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>National Centre for Infectious Diseases, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renia</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Lisa F P</ForeName><Initials>LFP</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASTAR Infectious Disease Labs, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bernett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;tzschke</LastName><ForeName>Olaf</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003289" MajorTopicYN="N">Convalescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS &#x2013; CoV &#x2013; 2</Keyword><Keyword MajorTopicYN="N">active infection</Keyword><Keyword MajorTopicYN="N">cytokine profile</Keyword><Keyword MajorTopicYN="N">immune recovery</Keyword><Keyword MajorTopicYN="N">immunophenotyping</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">severity</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34867943</ArticleId><ArticleId IdType="pmc">PMC8640498</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.710217</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet (2020) 395:497&#x2013;506. doi:&#xa0;10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Zhang C, Fan X, Meng FP, Xu Z, Xia P, et al. . Immunological and Inflammatory Profiles in Mild and Severe Cases of COVID-19. Nat Commun (2020) 11(1):3410. doi:&#xa0;10.1038/s41467-020-17240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JJ, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T, et al. . COVID-19-Associated Hyperinflammation and Escalation of Patient Care: A Retrospective Longitudinal Cohort Study. Lancet Rheumatol (2020) 2(10):e594&#x2013;602. doi:&#xa0;10.1016/S2665-9913(20)30275-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30275-7</ArticleId><ArticleId IdType="pmc">PMC7442426</ArticleId><ArticleId IdType="pubmed">32864628</ArticleId></ArticleIdList></Reference><Reference><Citation>Surveillances V. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China. China CDC Wkly (2020) 2:113&#x2013;22. doi:&#xa0;10.46234/ccdcw2020.032</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2020.032</ArticleId><ArticleId IdType="pmc">PMC8392929</ArticleId><ArticleId IdType="pubmed">34594836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouan Y, Guillon A, Gonzalez L, Perez Y, Ehrmann S, Ferreira M, et al. . Functional Alteration of Innate T Cells in Critically Ill Covid-19 Patients. medRxiv (2020) 2020. doi:&#xa0;10.1101/2020.05.03.20089300. 05.03.20089300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.03.20089300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, et al. . Comprehensive Mapping of Immune Perturbations Associated With Severe COVID-19. Sci Immunol (2020) 5(49):eabd7114. doi:&#xa0;10.1126/sciimmunol.abd7114</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd7114</ArticleId><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Carissimo G, Xu W, Kwok I, Abdad MY, Chan YH, Fong SW, et al. . Whole Blood Immunophenotyping Uncovers Immature Neutrophil-to-VD2 T-Cell Ratio as an Early Marker for Severe COVID-19. Nat Commun (2020) 11(1):5243. doi:&#xa0;10.1038/s41467-020-19080-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19080-6</ArticleId><ArticleId IdType="pmc">PMC7568554</ArticleId><ArticleId IdType="pubmed">33067472</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, et al. . Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe From Mild COVID-19. Cell (2020) 182(6):1401&#x2013;18.e18. doi:&#xa0;10.1016/j.cell.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J, Reusch N, Paclik D, Ba&#xdf;ler K, Schlickeiser S, Zhang B, et al. . Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell (2020) 182:1419&#x2013;40.e23. doi:&#xa0;10.1016/j.cell.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol (2020) 11:1446. doi:&#xa0;10.3389/fimmu.2020.01446</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LF, Anderson DE, Chia WN, Chia PY, et al. . Immunological and Viral Correlates of COVID-19 Disease Severity: A Prospective Cohort Study of the First 100 Patients in Singapore. SSRN Electron J (2020). doi:&#xa0;10.2139/ssrn.3576846</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3576846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. . Long-Term Consequences of COVID-19: Research Needs. Lancet Infect Dis (2020) 20:1115&#x2013;7. doi:&#xa0;10.1016/S1473-3099(20)30701-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-Month Consequences of COVID-19 in Patients Discharged From Hospital: A Cohort Study. Lancet (2021) 397:220&#x2013;32. doi:&#xa0;10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&amp;apos;em Y, et al. . Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. SSRN Electron J (2021) 38:101019. doi:&#xa0;10.2139/ssrn.3820561</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3820561</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipoor SD, Mortaz E, Jamaati H, Tabarsi P, Bayram H, Varahram M, et al. . COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol (2021) 11:563085. doi:&#xa0;10.3389/fcimb.2021.563085</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.563085</ArticleId><ArticleId IdType="pmc">PMC7904902</ArticleId><ArticleId IdType="pubmed">33643932</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY, et al. . Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis (2020) 73(9):e2932&#x2013;42. doi:&#xa0;10.1093/cid/ciaa1280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1280</ArticleId><ArticleId IdType="pmc">PMC7499509</ArticleId><ArticleId IdType="pubmed">32856707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Y, Fong S, Poh C, Carissimo G, Yeo NK, Amrun SN, et al. . Asymptomatic COVID-19: Disease Tolerance With Efficient Anti-Viral Immunity Against SARS-CoV-2. EMBO Mol Med (2021) 13:1&#x2013;15. doi:&#xa0;10.15252/emmm.202114045</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114045</ArticleId><ArticleId IdType="pmc">PMC8185544</ArticleId><ArticleId IdType="pubmed">33961735</ArticleId></ArticleIdList></Reference><Reference><Citation>Amid E, Warmuth MK. TriMap: Large-Scale Dimensionality Reduction Using Triplets. arXiv (2019).</Citation></Reference><Reference><Citation>McInnes L, Healy J, Melville J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction. arXiv (2018). doi: 10.21105/joss.00861</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.00861</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell MER, Taylor DR. Evaluation of Inactivation Methods for Severe Acute Respiratory Syndrome Coronavirus in Noncellular Blood Products. Transfusion (2006) 46(10):1770&#x2013;7. doi:&#xa0;10.1111/j.1537-2995.2006.00976.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2006.00976.x</ArticleId><ArticleId IdType="pmc">PMC7201869</ArticleId><ArticleId IdType="pubmed">17002634</ArticleId></ArticleIdList></Reference><Reference><Citation>Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. . Single-Cell RNA-Seq Reveals New Types of Human Blood Dendritic Cells, Monocytes, and Progenitors. Science (80-) (2017) 356(6335):eaah4573. doi:&#xa0;10.1126/science.aah4573</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah4573</ArticleId><ArticleId IdType="pmc">PMC5775029</ArticleId><ArticleId IdType="pubmed">28428369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. . Clinical Course and Outcome of 107 Patients Infected With the Novel Coronavirus, SARS-CoV-2, Discharged From Two Hospitals in Wuhan, China. Crit Care (2020) 24:1&#x2013;9. doi:&#xa0;10.1186/s13054-020-02895-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02895-6</ArticleId><ArticleId IdType="pmc">PMC7192564</ArticleId><ArticleId IdType="pubmed">32354360</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing AG, Lorenc A, del Molino del Barrio I, Das A, Fish M, Monin L, et al. . A Dynamic COVID-19 Immune Signature Includes Associations With Poor Prognosis. Nat Med (2020) 26:1623&#x2013;35. doi:&#xa0;10.1038/s41591-020-1038-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med (2020) 382:1708&#x2013;20. doi:&#xa0;10.1056/nejmoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. . Detection of 2019 Novel Coronavirus (2019-Ncov) by Real-Time RT-PCR. Eurosurveillance (2020) 25(3):2000045. doi:&#xa0;10.2807/1560-7917.ES.2020.25.3.2000045</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrot T, Gorin JB, Ponzetta A, Maleki KT, Kammann T, Emg&#xe5;rd J, et al. . MAIT Cell Activation and Dynamics Associated With COVID-19 Disease Severity. Sci Immunol (2020) 5(51):eabe1670. doi:&#xa0;10.1126/SCIIMMUNOL.ABE1670</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIIMMUNOL.ABE1670</ArticleId><ArticleId IdType="pmc">PMC7857393</ArticleId><ArticleId IdType="pubmed">32989174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Rustagi A, Zhao NQ, Roque J, Mart&#xed;nez-Col&#xf3;n GJ, McKechnie JL, et al. . A Single-Cell Atlas of the Peripheral Immune Response in Patients With Severe COVID-19. Nat Med (2020) 26(7):1070&#x2013;76. doi:&#xa0;10.1038/s41591-020-0944-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0944-y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Lo Tartaro D, Meschiari M, Gibellini L, Bellinazzi C, Borella R, et al. . Expansion of Plasmablasts and Loss of Memory B Cells in Peripheral Blood From COVID-19 Patients With Pneumonia. Eur J Immunol (2020) 50:1283&#x2013;94. doi:&#xa0;10.1002/eji.202048838</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048838</ArticleId><ArticleId IdType="pubmed">32910469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. . CellMarker: A Manually Curated Resource of Cell Markers in Human and Mouse. Nucleic Acids Res (2019) 47:D721&#x2013;8. doi:&#xa0;10.1093/nar/gky900</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky900</ArticleId><ArticleId IdType="pmc">PMC6323899</ArticleId><ArticleId IdType="pubmed">30289549</ArticleId></ArticleIdList></Reference><Reference><Citation>Funaro ADA, Delia D, Zaccolo M, Malavasi F, Giulio C, Roggero S, et al. . Involvement of the Multilineage CD38 Molecule in a Unique Pathway of Cell Activation and Proliferation. J Immunol (1990) 145:2390&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1976692</ArticleId></ArticleIdList></Reference><Reference><Citation>Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, et al. . Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member. J Immunol (1998) 160:395&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">9551996</ArticleId></ArticleIdList></Reference><Reference><Citation>Junker F, Gordon J, Qureshi O. Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Front Immunol (2020) 11:1393. doi:&#xa0;10.3389/fimmu.2020.01393</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01393</ArticleId><ArticleId IdType="pmc">PMC7350606</ArticleId><ArticleId IdType="pubmed">32719679</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrissey SM, Geller AE, Hu X, Tieri D, Cooke EA, Ding C, et al. . Emergence of Low-Density Inflammatory Neutrophils Correlates With Hypercoagulable State and Disease Severity in COVID-19 Patients. medRxiv (2020) 2020. doi:&#xa0;10.1101/2020.05.22.20106724. 05.22.20106724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.22.20106724</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. . Deep Immune Profiling of COVID-19 Patients Reveals Distinct Immunotypes With Therapeutic Implications. Science (80-) (2020) 369(6508):eabc8511. doi:&#xa0;10.1126/SCIENCE.ABC8511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABC8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Cerrillo I, Landete P, Aldave B, S&#xe1;nchez-Alonso S, S&#xe1;nchez-Azofra A, Marcos-Jim&#xe9;nez A, et al. . COVID-19 Severity Associates With Pulmonary Redistribution of CD1c+ DCs and Inflammatory Transitional and Nonclassical Monocytes. J Clin Invest (2020) 130:6290&#x2013;300. doi:&#xa0;10.1172/JCI140335</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140335</ArticleId><ArticleId IdType="pmc">PMC7685723</ArticleId><ArticleId IdType="pubmed">32784290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. . Pathogenic T-Cells and Inflammatory Monocytes Incite Inflammatory Storms in Severe COVID-19 Patients. Natl Sci Rev (2020) 7:998&#x2013;1002. doi:&#xa0;10.1093/nsr/nwaa041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal-Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong CHY, Petri B, et al. . A Dynamic Spectrum of Monocytes Arising From the in Situ Reprogramming of CCR2+ Monocytes at a Site of Sterile Injury. J Exp Med (2015) 212:447&#x2013;56. doi:&#xa0;10.1084/jem.20141539</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20141539</ArticleId><ArticleId IdType="pmc">PMC4387291</ArticleId><ArticleId IdType="pubmed">25800956</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold L, Henry A, Poron F, Baba-Amer Y, Van Rooijen N, Plonquet A, et al. . Inflammatory Monocytes Recruited After Skeletal Muscle Injury Switch Into Antiinflammatory Macrophages to Support Myogenesis. J Exp Med (2007) 204:1057&#x2013;69. doi:&#xa0;10.1084/jem.20070075</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20070075</ArticleId><ArticleId IdType="pmc">PMC2118577</ArticleId><ArticleId IdType="pubmed">17485518</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingaropoli MA, Perri V, Pasculli P, Cogliati Dezza F, Nijhawan P, Savelloni G, et al. . Major Reduction of NKT Cells in Patients With Severe COVID-19 Pneumonia. Clin Immunol (2021) 222:108630. doi:&#xa0;10.1016/j.clim.2020.108630</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108630</ArticleId><ArticleId IdType="pmc">PMC7661928</ArticleId><ArticleId IdType="pubmed">33189887</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B, Lee JM, Park YJ, Kim IK, Kim BS, Shin KS, et al. . Differentiation of C-Kit+CD24+ Natural Killer Cells Into Myeloid Cells in a GATA-2-Dependent Manner. FASEB J (2020) 34(3):4462&#x2013;81. doi:&#xa0;10.1096/fj.201902662R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902662R</ArticleId><ArticleId IdType="pubmed">31989715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortaz E, Tabarsi P, Varahram M, Folkerts G, Adcock IM. The Immune Response and Immunopathology of COVID-19. Front Immunol (2020) 11:2037. doi:&#xa0;10.3389/fimmu.2020.02037</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02037</ArticleId><ArticleId IdType="pmc">PMC7479965</ArticleId><ArticleId IdType="pubmed">32983152</ArticleId></ArticleIdList></Reference><Reference><Citation>Parackova Z, Zentsova I. Disharmonic Inflammatory Signatures in COVID-19&#x202f;. Cells (2020) 2:1&#x2013;17. doi:&#xa0;10.3390/cells9102206</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102206</ArticleId><ArticleId IdType="pmc">PMC7600406</ArticleId><ArticleId IdType="pubmed">33003471</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamone G, Giordano M, Trevani AS, Gamberale R, Vermeulen M, Schettinni J, et al. . Promotion of Neutrophil Apoptosis by TNF-&#x3b1;. J&#xa0;Immunol (2001) 166(5):3476&#x2013;83. doi:&#xa0;10.4049/jimmunol.166.5.3476</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.5.3476</ArticleId><ArticleId IdType="pubmed">11207306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross A, Moots RJ, Edwards SW. The Dual Effects of Tnf&#x3b1; on Neutrophil Apoptosis Are Mediated via Differential Effects on Expression of Mcl-1 and Bfl-1. Blood (2008) 111(2):878&#x2013;84. doi:&#xa0;10.1182/blood-2007-05-087833</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-05-087833</ArticleId><ArticleId IdType="pubmed">17942758</ArticleId></ArticleIdList></Reference><Reference><Citation>Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, et al. . VEGF-A Modulates Expression of Inhibitory Checkpoints on CD8++ T Cells in Tumors. J Exp Med (2015) 212(2):139&#x2013;48. doi:&#xa0;10.1084/jem.20140559</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140559</ArticleId><ArticleId IdType="pmc">PMC4322048</ArticleId><ArticleId IdType="pubmed">25601652</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, et al. . Postdischarge Thrombosis and Hemorrhage in Patients With COVID-19. Blood (2020) 136:1342&#x2013;6. doi:&#xa0;10.1182/blood.2020007938</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S, Pandey A. Rhino-Orbital Mucormycosis Associated With COVID-19. Cureus (2020) 12:10&#x2013;4. doi:&#xa0;10.7759/cureus.10726</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10726</ArticleId><ArticleId IdType="pmc">PMC7599039</ArticleId><ArticleId IdType="pubmed">33145132</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. . Impaired Immune Cell Cytotoxicity in Severe COVID-19 Is IL-6 Dependent. J&#xa0;Clin Invest (2020) 130:4694&#x2013;703. doi:&#xa0;10.1172/JCI138554</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138554</ArticleId><ArticleId IdType="pmc">PMC7456250</ArticleId><ArticleId IdType="pubmed">32463803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessmer MS, Fatima A, Paget C, Trottein F, Brossay L. NKT Cell Immune Responses to Viral Infection. Expert Opin Ther Targets (2009) 13:153&#x2013;62. doi: 10.1517/14712590802653601</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712590802653601</ArticleId><ArticleId IdType="pmc">PMC2921843</ArticleId><ArticleId IdType="pubmed">19236234</ArticleId></ArticleIdList></Reference><Reference><Citation>Leliefeld PHC, Wessels CM, Leenen LPH, Koenderman L, Pillay J. The Role of Neutrophils in Immune Dysfunction During Severe Inflammation. Crit Care (2016) 20:1&#x2013;9. doi:&#xa0;10.1186/s13054-016-1250-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1250-4</ArticleId><ArticleId IdType="pmc">PMC4804478</ArticleId><ArticleId IdType="pubmed">27005275</ArticleId></ArticleIdList></Reference><Reference><Citation>Meghraoui-Kheddar A, Chousterman B, Guillou N, Barone S, Granjeaud S, Vallet H, et al. . Two New Immature and Dysfunctional Neutrophil Cell Subsets Define a Predictive Signature of Sepsis Useable in Clinical Practice. bioRxiv (2020) 1&#x2013;36. doi:&#xa0;10.1101/2020.05.29.123992</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.29.123992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li Q, Yin Y, Zhang Y, Cao Y, Lin X, et al. . Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19. Front Immunol (2020) 11:2063. doi:&#xa0;10.3389/fimmu.2020.02063</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02063</ArticleId><ArticleId IdType="pmc">PMC7461898</ArticleId><ArticleId IdType="pubmed">33013872</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. . Targeting Potential Drivers of COVID-19: Neutrophil Extracellular Traps. J Exp Med (2020) 217(6):e20200652. doi:&#xa0;10.1084/jem.20200652</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200652</ArticleId><ArticleId IdType="pmc">PMC7161085</ArticleId><ArticleId IdType="pubmed">32302401</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. . A Pathological Report of Three COVID-19 Cases by Minimally Invasive Autopsies. Zhonghua bing li xue za zhi = Chin J Pathol (2020) 49(5):411&#x2013;7. doi:&#xa0;10.3760/cma.j.cn112151-20200312-00193</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112151-20200312-00193</ArticleId><ArticleId IdType="pubmed">32172546</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox S, Akmatbekov A, Harbert J, Li G, Brown JQ, Vander Heide R. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series From New Orleans. Lancet Respir Med (2020) 8(7):681&#x2013;6. doi:&#xa0;10.1101/2020.04.06.20050575</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.06.20050575</ArticleId><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Su K. Neutrophil Extracellular Traps and Systemic Lupus Erythematosus. J Clin Cell Immunol (2013) 4:139. doi:&#xa0;10.4172/2155-9899.1000139</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000139</ArticleId><ArticleId IdType="pmc">PMC3826916</ArticleId><ArticleId IdType="pubmed">24244889</ArticleId></ArticleIdList></Reference><Reference><Citation>Radermecker C, Detrembleur N, Guiot J, Cavalier E, Henket M, d&#x2019;Emal C, et al. . Neutrophil Extracellular Traps Infiltrate the Lung Airway, Interstitial, and Vascular Compartments in Severe COVID-19. J Exp Med (2020) 217(12):e20201012. doi:&#xa0;10.1084/jem.20201012</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201012</ArticleId><ArticleId IdType="pmc">PMC7488867</ArticleId><ArticleId IdType="pubmed">32926097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauracher L-M, Krall M, Roi&#xdf; J, Hell L, Koder S, Hofbauer TM, et al. . Neutrophil Subpopulations and Their Activation Potential in Patients With Antiphospholipid Syndrome and Healthy Individuals. Rheumatology (2020) 60(4):1687&#x2013;99. doi:&#xa0;10.1093/rheumatology/keaa532</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa532</ArticleId><ArticleId IdType="pmc">PMC8024003</ArticleId><ArticleId IdType="pubmed">33026085</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Hoogen LL, van der Linden M, Meyaard L, Fritsch-Stork RDE, Van Roon JA, Radstake TRDJ. Neutrophil Extracellular Traps and Low-Density Granulocytes Are Associated With the Interferon Signature in Systemic Lupus Erythematosus, But Not in Antiphospholipid Syndrome. Ann Rheum Dis (2020) 79(10):e135. doi:&#xa0;10.1136/annrheumdis-2019-215781</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215781</ArticleId><ArticleId IdType="pubmed">31177097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ui Mhaonaigh A, Coughlan AM, Dwivedi A, Hartnett J, Cabral J, Moran B, et al. . Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies. Front Immunol (2019) 10:2603. doi:&#xa0;10.3389/fimmu.2019.02603</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02603</ArticleId><ArticleId IdType="pmc">PMC6856659</ArticleId><ArticleId IdType="pubmed">31781107</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, et al. . Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis. Am J Pathol (2011) 179:199&#x2013;210. doi:&#xa0;10.1016/j.ajpath.2011.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.03.013</ArticleId><ArticleId IdType="pmc">PMC3123873</ArticleId><ArticleId IdType="pubmed">21703402</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Li B, Ma H, Wang X, Cai P, Yu Q, et al. . Single-Cell Analysis of Two Severe COVID-19 Patients Reveals a Monocyte-Associated and Tocilizumab-Responding Cytokine Storm. Nat Commun (2020) 11(1):3924. doi:&#xa0;10.1038/s41467-020-17834-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17834-w</ArticleId><ArticleId IdType="pmc">PMC7413381</ArticleId><ArticleId IdType="pubmed">32764665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Guo R, Lei L, Liu H, Wang Y, Wang Y, et al. . Frontline Science: COVID-19 Infection Induces Readily Detectable Morphologic and Inflammation-Related Phenotypic Changes in Peripheral Blood Monocytes. J Leukoc Biol (2021) 109:13&#x2013;22. doi:&#xa0;10.1002/JLB.4HI0720-470R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4HI0720-470R</ArticleId><ArticleId IdType="pmc">PMC7675546</ArticleId><ArticleId IdType="pubmed">33040384</ArticleId></ArticleIdList></Reference><Reference><Citation>Peruzzi B, Bencini S, Capone M, Mazzoni A, Maggi L, Salvati L, et al. . Quantitative and Qualitative Alterations of Circulating Myeloid Cells and Plasmacytoid DC in SARS-CoV-2 Infection. Immunology (2020) 161:345&#x2013;53. doi:&#xa0;10.1111/imm.13254</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13254</ArticleId><ArticleId IdType="pmc">PMC7692244</ArticleId><ArticleId IdType="pubmed">32870529</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. . Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients. Science (80-) (2020) 369(6504):718&#x2013;24. doi:&#xa0;10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o D, Garc&#xed;a LF, Rojas M. Increased Frequency and Cell Death of CD16 + Monocytes With Mycobacterium Tuberculosis Infection. Tuberculosis (2011) 91:348&#x2013;60. doi:&#xa0;10.1016/j.tube.2011.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tube.2011.04.002</ArticleId><ArticleId IdType="pubmed">21621464</ArticleId></ArticleIdList></Reference><Reference><Citation>Belge K-U, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. . The Proinflammatory CD14 + CD16 + DR ++ Monocytes Are a Major Source of TNF. J Immunol (2002) 168:3536&#x2013;42. doi:&#xa0;10.4049/jimmunol.168.7.3536</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.7.3536</ArticleId><ArticleId IdType="pubmed">11907116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KL, Tai JJY, Wong WC, Han H, Sem X, Yeap WH, et al. . Gene Expression Profiling Reveals the Defining Features of the Classical, Intermediate,and Nonclassical Human Monocyte Subsets. Blood (2011) 118:16&#x2013;31. doi:&#xa0;10.1182/blood-2010-12-326355</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-12-326355</ArticleId><ArticleId IdType="pubmed">21653326</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G, Tacke R, Hedrick CC, Hanna RN. Nonclassical Patrolling Monocyte Function in the Vasculature. Arterioscler Thromb Vasc Biol (2015) 35:1306&#x2013;16. doi:&#xa0;10.1161/ATVBAHA.114.304650</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.114.304650</ArticleId><ArticleId IdType="pmc">PMC4441550</ArticleId><ArticleId IdType="pubmed">25838429</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan PB, Marcovecchio P, Hamers AAJ, Hedrick CC. Nonclassical Monocytes in Health and Disease. Annu Rev Immunol (2019) 37:439&#x2013;56. doi:&#xa0;10.1146/annurev-immunol-042617-053119</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053119</ArticleId><ArticleId IdType="pubmed">31026415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimen M, Yates CM, McGettrick HM, Ward LSC, Harrison MJ, Apta B, et al. . Monocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling Through TNF and IL-6 at the Endothelial Cell Interface. J Immunol (2017) 198:2834&#x2013;43. doi:&#xa0;10.4049/jimmunol.1601281</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601281</ArticleId><ArticleId IdType="pmc">PMC5357784</ArticleId><ArticleId IdType="pubmed">28193827</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalak R, Raton B, Dembo M, Kaverina I, Small JV, Wang YL, et al. . References and Notes 1. Science (2007) 317:666&#x2013;71. doi:&#xa0;10.1126/science.1142883</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1142883</ArticleId></ArticleIdList></Reference><Reference><Citation>Olingy CE, San Emeterio CL, Ogle ME, Krieger JR, Bruce AC, Pfau DD, et al. . Non-Classical Monocytes Are Biased Progenitors of Wound Healing Macrophages During Soft Tissue Injury. Sci Rep (2017) 7:1&#x2013;16. doi:&#xa0;10.1038/s41598-017-00477-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00477-1</ArticleId><ArticleId IdType="pmc">PMC5428475</ArticleId><ArticleId IdType="pubmed">28348370</ArticleId></ArticleIdList></Reference><Reference><Citation>Delneste Y, Charbonnier P, Herbault N, Magistrelli G, Caron G, Bonnefoy JY, et al. . Interferon-&#x3b3; Switches Monocyte Differentiation From Dendritic Cells to Macrophages. Blood (2003) 101:143&#x2013;50. doi:&#xa0;10.1182/blood-2002-04-1164</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-04-1164</ArticleId><ArticleId IdType="pubmed">12393446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-Classical Monocytes Display Inflammatory Features: Validation in Sepsis and Systemic Lupus Erythematous. Sci Rep (2015) 5:1&#x2013;14. doi:&#xa0;10.1038/srep13886</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13886</ArticleId><ArticleId IdType="pmc">PMC4566081</ArticleId><ArticleId IdType="pubmed">26358827</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. . CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol (2016) 7:512. doi:&#xa0;10.3389/fimmu.2016.00512</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00512</ArticleId><ArticleId IdType="pmc">PMC5116853</ArticleId><ArticleId IdType="pubmed">27917174</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto BF, Medeiros NI, Teixeira-Carvalho A, Eloi-Santos SM, Fontes-Cal TCM, Rocha DA, et al. . CD86 Expression by Monocytes Influence an Immunomodulatory Profile in Asymptomatic Patients With Chronic Chagas Disease. Front Immunol (2018) 9:454. doi:&#xa0;10.3389/fimmu.2018.00454</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00454</ArticleId><ArticleId IdType="pmc">PMC5857740</ArticleId><ArticleId IdType="pubmed">29599775</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, et al. . A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans. PloS One (2015) 10:1&#x2013;19. doi:&#xa0;10.1371/journal.pone.0121546</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121546</ArticleId><ArticleId IdType="pmc">PMC4370675</ArticleId><ArticleId IdType="pubmed">25799053</ArticleId></ArticleIdList></Reference><Reference><Citation>Testa U, Pelosi E, Castelli G. CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies. Cancers (Basel) (2019) 11(9):1358. doi:&#xa0;10.3390/cancers11091358</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11091358</ArticleId><ArticleId IdType="pmc">PMC6769702</ArticleId><ArticleId IdType="pubmed">31547472</ArticleId></ArticleIdList></Reference><Reference><Citation>Geissmann F, Jung S, Littman DR. Blood Monocytes Consist of Two Principal Subsets With Distinct Migratory Properties. Immunity (2003) 19:71&#x2013;82. doi:&#xa0;10.1016/S1074-7613(03)00174-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(03)00174-2</ArticleId><ArticleId IdType="pubmed">12871640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehto J, Ninou AH, Chioureas D, Jonkers J, Gustafsson NMS. Targeting Cx3cr1 Suppresses the Fanconi Anemia Dna Repair Pathway and Synergizes With Platinum. Cancers (Basel) (2021) 13:1&#x2013;15. doi:&#xa0;10.3390/cancers13061442</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13061442</ArticleId><ArticleId IdType="pmc">PMC8004634</ArticleId><ArticleId IdType="pubmed">33810010</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Hall E, et al. . Persistence of SARS CoV-2 S1 Protein in CD16 + Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection. bioRxiv (2021). doi: 10.1101/2021.06.25.449905</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.25.449905</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Cla&#xeb;r L, et al. . IgA Dominates the Early Neutralizing Antibody Response to SARS-CoV-2. Sci Transl Med (2021) 13(577):eabd2223. doi:&#xa0;10.1126/scitranslmed.abd2223</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2223</ArticleId><ArticleId IdType="pmc">PMC7857408</ArticleId><ArticleId IdType="pubmed">33288662</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. . Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis (2020) 71:778&#x2013;85. doi:&#xa0;10.1093/cid/ciaa310</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa310</ArticleId><ArticleId IdType="pmc">PMC7184472</ArticleId><ArticleId IdType="pubmed">32198501</ArticleId></ArticleIdList></Reference><Reference><Citation>Breedveld A, Van Egmond M. IgA and Fc&#x3b1;ri: Pathological Roles and Therapeutic Opportunities. Front Immunol (2019) 10:553. doi:&#xa0;10.3389/fimmu.2019.00553</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00553</ArticleId><ArticleId IdType="pmc">PMC6448004</ArticleId><ArticleId IdType="pubmed">30984170</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleyd E, Heineke MH, van Egmond M. The Era of the Immunoglobulin A Fc Receptor Fc&#x3b1;ri; Its Function and Potential as Target in Disease. Immunol Rev (2015) 268:123&#x2013;38. doi:&#xa0;10.1111/imr.12337</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12337</ArticleId><ArticleId IdType="pubmed">26497517</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyette LB, MacEdo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, et al. . Function, and Differentiation Potential of Human Monocyte Subsets. PloS One (2017) 12:1&#x2013;20. doi:&#xa0;10.1371/journal.pone.0176460</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0176460</ArticleId><ArticleId IdType="pmc">PMC5406034</ArticleId><ArticleId IdType="pubmed">28445506</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez SM, Taborda NA, Rugeles MT. Role of Different Subpopulations of CD8+ T Cells During HIV Exposure and Infection. Front Immunol (2017) 8:936. doi:&#xa0;10.3389/fimmu.2017.00936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00936</ArticleId><ArticleId IdType="pmc">PMC5545716</ArticleId><ArticleId IdType="pubmed">28824656</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, et al. . Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines. Immunity (2008) 28:710&#x2013;22. doi:&#xa0;10.1016/j.immuni.2008.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.02.020</ArticleId><ArticleId IdType="pubmed">18468462</ArticleId></ArticleIdList></Reference><Reference><Citation>Reagin KL, Klonowski KD. Incomplete Memories: The Natural Suppression of Tissue-Resident Memory CD8 T Cells in the Lung. Front Immunol (2018) 9:17. doi:&#xa0;10.3389/fimmu.2018.00017</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00017</ArticleId><ArticleId IdType="pmc">PMC5786534</ArticleId><ArticleId IdType="pubmed">29403499</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>